Viewing Study NCT04208958


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2025-12-25 @ 9:58 PM
Study NCT ID: NCT04208958
Status: COMPLETED
Last Update Posted: 2025-10-27
First Post: 2019-12-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Sponsor: Vedanta Biosciences, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-01-23
Start Date Type: ACTUAL
Primary Completion Date: 2021-08-26
Primary Completion Date Type: ACTUAL
Completion Date: 2023-02-23
Completion Date Type: ACTUAL
First Submit Date: 2019-12-16
First Submit QC Date: None
Study First Post Date: 2019-12-23
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-08-29
Results First Submit QC Date: None
Results First Post Date: 2023-08-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-30
Last Update Post Date: 2025-10-27
Last Update Post Date Type: ESTIMATED